27 related articles for article (PubMed ID: 2421018)
1. Characterization of beta-adrenergic receptors in duck cerebral cortex.
Zawilska JB; Zalewska-Kaszubska J; Marczak G; Górska D; Woldan-Tambor A
Acta Neurobiol Exp (Wars); 2000; 60(3):301-7. PubMed ID: 11016072
[TBL] [Abstract][Full Text] [Related]
2. A prospective pilotstudy comparing the anesthetic effects of an alpha-2 agonist during holmium laser resection of the prostate and transurethral resection for prostate surgery for benign prostatic hyperplasia patients using selective alpha-1 blockers.
Lee DW; Baik J; Yun G; Jeon S; Kim HJ; Kim ES; Lee HJ; Kwon JY
BMC Anesthesiol; 2018 Sep; 18(1):136. PubMed ID: 30261833
[TBL] [Abstract][Full Text] [Related]
3. Lower urinary tract symptoms in men.
Hollingsworth JM; Wilt TJ
BMJ; 2014 Aug; 349():g4474. PubMed ID: 25125424
[TBL] [Abstract][Full Text] [Related]
4. Is there a peripheral site of action contributing to the voiding effects of α₂-adrenoceptor agonists and antagonists?
Aro E; Bastman S; Andersson KE; Streng T
World J Urol; 2015 Mar; 33(3):433-40. PubMed ID: 24903349
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of benign prostatic hyperplasia: insights from medical therapy for the disease.
Lepor H
Rev Urol; 2009; 11(Suppl 1):S9-S13. PubMed ID: 20126609
[TBL] [Abstract][Full Text] [Related]
6. Alpha blockers for the treatment of benign prostatic hyperplasia.
Lepor H
Rev Urol; 2007; 9(4):181-90. PubMed ID: 18231614
[TBL] [Abstract][Full Text] [Related]
7. The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia.
Lepor H
Rev Urol; 2006; 8 Suppl 4(Suppl 4):S3-9. PubMed ID: 17215999
[TBL] [Abstract][Full Text] [Related]
8. The medical therapy of prostatic symptoms study: what will we learn?
Slawin KM
Rev Urol; 2003; 5 Suppl 5(Suppl 5):S36-41. PubMed ID: 16985969
[TBL] [Abstract][Full Text] [Related]
9. The medical therapy of prostatic symptoms study: what will we learn?
Slawin KM
Rev Urol; 2003; 5 Suppl 4(Suppl 4):S42-7. PubMed ID: 16985963
[TBL] [Abstract][Full Text] [Related]
10. Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.
Michel MC; Vrydag W
Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S88-119. PubMed ID: 16465187
[TBL] [Abstract][Full Text] [Related]
11. Benign prostatic hyperplasia. Practical treatment guidelines.
Tammela T
Drugs Aging; 1997 May; 10(5):349-66. PubMed ID: 9143856
[TBL] [Abstract][Full Text] [Related]
12. Characterization of [3H]rauwolscine binding to alpha 2-adrenoceptor sites in the lumbar spinal cord of the cat: comparison to such binding sites in the cat frontal cerebral cortex.
Howe JR; Yaksh TL
Brain Res; 1986 Mar; 368(1):87-100. PubMed ID: 2869820
[TBL] [Abstract][Full Text] [Related]
13. Effects of dicentrine, a novel alpha 1-adrenoceptor antagonist, on human hyperplastic prostates.
Yu SM; Ko FN; Chueh SC; Chen J; Chen SC; Chen CC; Teng CM
Eur J Pharmacol; 1994 Jan; 252(1):29-34. PubMed ID: 7512043
[TBL] [Abstract][Full Text] [Related]
14. The alpha adrenergic binding properties of terazosin in the human prostate adenoma and canine brain.
Lepor H; Baumann M; Shapiro E
J Urol; 1988 Sep; 140(3):664-7. PubMed ID: 2457715
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of alpha-2 adrenergic receptors.
Bylund DB
Pharmacol Biochem Behav; 1985 May; 22(5):835-43. PubMed ID: 2989948
[TBL] [Abstract][Full Text] [Related]
16. Alpha 2 adrenergic receptors in hyperplastic human prostate: identification and characterization using [3H] rauwolscine.
Shapiro E; Lepor H
J Urol; 1986 May; 135(5):1038-42. PubMed ID: 2421018
[TBL] [Abstract][Full Text] [Related]
17. Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia.
Lepor H; Shapiro E
J Urol; 1984 Dec; 132(6):1226-9. PubMed ID: 6209426
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
